{"entity":{"type":"insider","cik":"0001378874","url":"/insider/0001378874","json_url":"/insider/0001378874.json","name":"Weinstein Jack","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":7,"first":"2007-08-16","last":"2010-12-21","span_basis":"filed_date"},"name_variants":[{"name":"Weinstein Jack","source":"filing","n_filings":7,"first_seen":"2007-08-16","last_seen":"2010-12-21"}],"transactions":[{"id":7759990,"accession":"0001161697-10-001176","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-10-001176","line_url":"/filing/0001161697-10-001176","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"Catalyst Pharmaceutical Partners, Inc.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378874","owner_name":"Weinstein Jack","owner_display_name":"Weinstein Jack","owner_url":"/insider/0001378874","role":"Officer (V.P., Treasurer & CFO)","role_mark":"O","role_mark_label":"Officer (V.P., Treasurer & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"V.P., Treasurer & CFO","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":0.95112,"price_display":"0.95","price_state":"stated","total_value":2377.8,"total_display":"2,377.80","total_whole":"2,378","shares_owned_after":13993.0,"shares_owned_after_display":"13,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-20","filed_date":"2010-12-21","scope":"insider","n_lines":2},{"id":5688300,"accession":"0001161697-09-000247","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-09-000247","line_url":"/filing/0001161697-09-000247#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"Catalyst Pharmaceutical Partners, Inc.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378874","owner_name":"Weinstein Jack","owner_display_name":"Weinstein Jack","owner_url":"/insider/0001378874","role":"Officer (V.P., Treasurer & CFO)","role_mark":"O","role_mark_label":"Officer (V.P., Treasurer & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"V.P., Treasurer & CFO","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1400.0,"shares_display":"1,400","price_per_share":1.55,"price_display":"1.55","price_state":"stated","total_value":2170.0,"total_display":"2,170.00","total_whole":"2,170","shares_owned_after":11993.0,"shares_owned_after_display":"11,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-06","filed_date":"2009-03-06","scope":"insider"},{"id":3566117,"accession":"0001161697-08-001353","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-08-001353","line_url":"/filing/0001161697-08-001353#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"Catalyst Pharmaceutical Partners, Inc.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378874","owner_name":"Weinstein Jack","owner_display_name":"Weinstein Jack","owner_url":"/insider/0001378874","role":"Officer (V.P., Treasurer & CFO)","role_mark":"O","role_mark_label":"Officer (V.P., Treasurer & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"V.P., Treasurer & CFO","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":2.24,"price_display":"2.24","price_state":"stated","total_value":224.0,"total_display":"224.00","total_whole":"224","shares_owned_after":10593.0,"shares_owned_after_display":"10,593","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-12-18","filed_date":"2008-12-22","scope":"insider"},{"id":4151742,"accession":"0001161697-08-001172","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-08-001172","line_url":"/filing/0001161697-08-001172#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"Catalyst Pharmaceutical Partners, Inc.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378874","owner_name":"Weinstein Jack","owner_display_name":"Weinstein Jack","owner_url":"/insider/0001378874","role":"Officer (V.P., Treasurer & CFO)","role_mark":"O","role_mark_label":"Officer (V.P., Treasurer & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"V.P., Treasurer & CFO","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":3.028,"price_display":"3.03","price_state":"stated","total_value":302.8,"total_display":"302.80","total_whole":"303","shares_owned_after":10493.0,"shares_owned_after_display":"10,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-02","filed_date":"2008-10-30","scope":"insider"},{"id":3934318,"accession":"0001161697-08-001064","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-08-001064","line_url":"/filing/0001161697-08-001064","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"Catalyst Pharmaceutical Partners, Inc.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378874","owner_name":"Weinstein Jack","owner_display_name":"Weinstein Jack","owner_url":"/insider/0001378874","role":"Officer (V.P., Treasurer & CFO)","role_mark":"O","role_mark_label":"Officer (V.P., Treasurer & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"V.P., Treasurer & CFO","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":2.9125,"price_display":"2.91","price_state":"stated","total_value":1165.0,"total_display":"1,165.00","total_whole":"1,165","shares_owned_after":10293.0,"shares_owned_after_display":"10,293","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-25","filed_date":"2008-09-26","scope":"insider","n_lines":2},{"id":2381057,"accession":"0001161697-08-001040","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001161697-08-001040","line_url":"/filing/0001161697-08-001040","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"Catalyst Pharmaceutical Partners, Inc.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378874","owner_name":"Weinstein Jack","owner_display_name":"Weinstein Jack","owner_url":"/insider/0001378874","role":"Officer (V.P., Treasurer & CFO)","role_mark":"O","role_mark_label":"Officer (V.P., Treasurer & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"V.P., Treasurer & CFO","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":2.5362766666666667,"price_display":"2.54","price_state":"stated","total_value":7608.83,"total_display":"7,608.83","total_whole":"7,609","shares_owned_after":9993.0,"shares_owned_after_display":"9,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-17","filed_date":"2008-09-18","scope":"insider","n_lines":3},{"id":7558446,"accession":"0001161697-07-000940","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-07-000940","line_url":"/filing/0001161697-07-000940#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"Catalyst Pharmaceutical Partners, Inc.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001378874","owner_name":"Weinstein Jack","owner_display_name":"Weinstein Jack","owner_url":"/insider/0001378874","role":"Officer (V.P., Treasurer & CFO)","role_mark":"O","role_mark_label":"Officer (V.P., Treasurer & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"V.P., Treasurer & CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":15000.0,"total_display":"15,000.00","total_whole":"15,000","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-14","filed_date":"2007-08-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":11,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001369568","name":"Catalyst Pharmaceutical Partners, Inc.","url":"/issuer/0001369568","role":"Officer (V.P., Treasurer & CFO)","n_filings":7,"first_seen":"2007-08-16","last_seen":"2010-12-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001378874","retrieved_at":"2026-08-24T03:00:16+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}